πŸ‡ΊπŸ‡Έ FDA
Patent

US 10272051

Method to treat atopic dermatitis

granted A61KA61K31/05A61K31/352

Quick answer

US patent 10272051 (Method to treat atopic dermatitis) held by AXIM BIOTECHNOLOGIES. INC. expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXIM BIOTECHNOLOGIES. INC.
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/05, A61K31/352, A61K31/658, A61K47/44